The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Remission on thiopurinic immunomodulators normalizes quality of life and psychological status in patients with Crohnʼs disease
Abstract
BACKGROUND: Thiopurinic immunomodulators are effective for maintaining symptom remission in Crohn's disease. Little is known, however, about their effect on patients' quality of life or psychological well-being. The present study aimed to determine whether remission induced by thiopurinic immunomodulators returns levels of quality of life and psychological well-being to normal. MATERIALS AND METHODS: A case-control study was performed. Cases were 33 patients with Crohn's disease treated with azathioprine or 6-mercaptopurine and in stable remission for at least 6 months. Sixty-six healthy individuals matched 2:1 by age and sex and 14 patients with active Crohn's disease were included as control groups. Quality of life was evaluated with the Short Form (SF-36) questionnaire, and the respective Hamilton rating scales were used for anxiety and depression. ANOVA with Bonferroni's correction was used for multiple comparisons. RESULTS: SF-36 global scores were 85 in the study group, 85 in healthy controls (P = 1), and 58.6 in patients with active disease (P < 0.001 for the comparison with the other 2 groups). The differences between values were 0 (95% CI -4-4), 26.4 (95% CI 20-32), and 26.4 (95% CI 19-33), respectively. The respective anxiety and depression scores were 6.5, 5.5, and 16.2 and 3.7, 3.3, and 10.9. No significant differences were observed in any of the SF-36 domains between case and control groups, whereas in patients with active disease, all domains were significantly worse. CONCLUSIONS: Thiopurinic immunomodulator-induced remission restores normal levels of quality of life and psychological well-being in Crohn's disease patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In adults, rates of depression in inactive IBD ranged from 0 in one small study (n=33) to 49.6% (95% CI ±14.3) in another small study (n=47).
“In adults, the rates of depression in inactive IBD ranged from 0 in one small study (n=33) (18) to 49.6% (±14.3, 95% CI) in another small study (n=47) (40).”
From Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases (2016) · cites this paper as [18]
During active IBD, rates of depression ranged from 14% (95% CI ±18.2) in a small case-control study to 50% (±18.5) in a small prospective study (n=28).
“During active disease, the rates of depression ranged from 14% (± 18.2, 95% CI) in a small case-control study (18) to 50% (± 18.5, 95% CI) in a small prospective study (n=28) (40).”
From Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases (2016) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L., Schreiber, S., Colombel, J., Rachmilewitz, D., Wolf, D. C., Olson, A. D., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,164
A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY
Harvey, R. F., & Bradshaw, J. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92767-1 · Cited by 2,974
(1995) · PubMed · Cited by 950
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Prefontaine, E., MacDonald, J. K., & Sutherland, L. R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000545.pub3 · Cited by 603
Depression and anxiety in people with inflammatory bowel disease
Kurina, L. M., Goldacre, M. J., Yeates, D., & Gill, L. E. (2001) · Journal of Epidemiology & Community Health · doi:10.1136/jech.55.10.716 · Cited by 347
Azathioprine for maintenance of remission in Crohn's disease
Pearson, D., May, G., Fick, G. H., & Sutherland, L. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000067 · Cited by 304
Casellas, F., Arenas, J. I., Baudet, J. S., Fábregas, S., García, N. C., Gelabert, J., Medina, C., Ochotorena, I., Papo, M., Rodrigo, L., et al. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000159661.55028.56 · Cited by 269
Self-citationLichtenstein, G. R., Yan, S., BALA, M. M., & Hanauer, S. B. (2004) · The American Journal of Gastroenterology · doi:10.1046/j.1572-0241.2003.04010.x · Cited by 266
PERSOONS, P., VERMEIRE, S., DEMYTTENAERE, K., FISCHLER, B., VANDENBERGHE, J., VAN OUDENHOVE, L., PIERIK, M., HLAVATY, T., VAN ASSCHE, G., NOMAN, M., et al. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02535.x · Cited by 253
The quality of life in patients with Crohn's disease
Cohen, R. D. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01323.x · Cited by 253
Addolorato, G., Capristo, E., Stefanini, G. F., & Gasbarrini, A. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011218 · Cited by 243
Mardini, H. E., Kip, K. E., & Wilson, J. W. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000020509.23162.cc · Cited by 211
Simrén, M. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)04037-0 · Cited by 186
The role of anxiety and depression in the irritable bowel syndrome
Blanchard, E. B., Scharff, L., Schwarz, S. P., Suls, J. M., & Barlow, D. H. (1990) · Behaviour Research and Therapy · doi:10.1016/0005-7967(90)90159-g · Cited by 167
Influence of inflammatory bowel disease on different dimensions of quality of life
Casellas, F., López-Vivancos, J., Badia, X. C., Vilaseca, J., & Malagelada, J. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200105000-00017 · Cited by 167
Self-citationInfliximab Improves Quality of Life in Patients with Crohn's Disease
Lichtenstein, G. R., BALA, M. M., Han, C., DeWoody, K. L., & Schaible, T. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200207000-00001 · Cited by 165
The Effects of Infliximab Maintenance Therapy on Health-Related Quality of Life
Feagan, B. G., Yan, S., BALA, M. M., Bao, W., & Lichtenstein, G. R. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07674.x · Cited by 138
Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients.
Blondel-Kucharski, F., Chircop, C., Marquis, P., Cortot, A., Baron, F., Jp, G., & Colombel, J. (2001) · PubMed · doi:10.1111/j.1572-0241.2001.4681_b.x · Cited by 134
Evaluation of a psychological treatment for inflammatory bowel disease
Schwarz, S. P., & Blanchard, E. B. (1991) · Behaviour Research and Therapy · doi:10.1016/0005-7967(91)90045-5 · Cited by 131
MEASURING CROHN'S DISEASE ACTIVITY
Harvey, R., & Bradshaw, M. J. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91577-9 · Cited by 122
Health-related quality of life in Crohn’s disease: a prospective longitudinal study in 231 patients
Blondel-Kucharski, F., Chircop, C., Marquis, P., Cortot, A., Baron, F., Gendre, J.-P., Colombel, J.-F., & (GETAID), T. G. D. T. D. A. I. D. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04681.x · Cited by 120
Impact of surgery for Crohn's disease on health-related quality of life
Casellas, F., López-Vivancos, J., Badia, X. C., Vilaseca, J., & Malagelada, J. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01681.x · Cited by 101
Self-citationBernklev, T., Jahnsen, J., Schulz, T. B., Sauar, J., Lygren, I., Henriksen, M., Stray, N., Kjellevold, Y., Aadland, E., Vatn, M., et al. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200510000-00006 · Cited by 93
Li, J., Nørgård, B. M., Precht, D. H., & Olsen, J. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04155.x · Cited by 84
Casellas, F., Alcalá, M.-J., Prieto, L. M., Armengol, J., & Malagelada, J. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04071.x · Cited by 83
Self-citationDevelopment and validation of a computer-administered version of the Hamilton Rating Scale.
Kobak, K. A., Reynolds, W. M., & Greist, J. H. (1993) · Psychological Assessment · doi:10.1037/1040-3590.5.4.487 · Cited by 76
Psychological distress and levels of disease activity in inflammatory bowel disease.
Porcelli, P., Zaka, S., Centonze, S., & Sisto, G. (1994) · PubMed · Cited by 71
Andersson, P., Olaison, G., Bendtsen, P., Myrelid, P., & Sjödahl, R. I. (2003) · Colorectal Disease · doi:10.1046/j.1463-1318.2003.00407.x · Cited by 65
Does Better Disease-Related Education Improve Quality of Life?
Verma, S., Tsai, H. H., & Giaffer, M. H. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1010725106411 · Cited by 61
Quality of Life Improves Within 30 Days of Surgery for Crohn’s Disease
Delaney, C. P., Kiran, R. P., Senagore, A. J., Ermlich, B., Church, J. M., Hull, T. L., Remzi, F. H., & Fazio, V. W. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00131-5 · Cited by 57
Quality of life in inflammatory bowel disease.
Martín, A., Leone, L., Fries, W., & Naccarato, R. (1995) · PubMed · Cited by 49
Quality of life rapidly improves with budesonide therapy for active Crohn's disease
Irvine, E. J., Greenberg, G. R., Feagan, B. G., Martin, F., Sutherland, L. R., Thomson, A. B. R., Nilsson, L.-G., & Persson, T. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780060305 · Cited by 40
Effects of anti‐tumour necrosis factor‐α therapy on the quality of life in Crohn's disease
Balkom, B. P. J. V., Schoon, E. J., Stockbrügger, R. W., Wolters, F. J., van Hogezand, R. A., van Deventer, S. J. H., Oldenburg, B., van Dullemen, H. M., & Rüssel, M. G. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01268.x · Cited by 33
Quality of Life Rapidly Improves with Budesonide Therapy for Active Crohnʼs Disease
Irvine, J. E., Greenberg, G. R., Feagan, B. G., Martin, F., Sutherland, L. R., Thomson, A. B. R., Nilsson, L.-G., & Persson, T. (2000) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200008000-00004 · Cited by 32
Budesonide and Mesalazine in Active Crohn's Disease: A Comparison of The Effects on Quality of Life
Thomsen, O. Ø., Cortot, A., Jewell, D. P., WRIGHT, J. P., Winter, T. A., Veloso, F. T., Vatn, M., Persson, T., & Pettersson, E. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)04106-5 · Cited by 26
Cadahía, V., García-Carbonero, A., Vivas, S., Fuentes, D., Niño, P., Rebollo, P., & Rodrigo, L. (2004) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082004000600002 · Cited by 24
Projective Personality Tests of Children with Inflammatory Bowel Disease
Krall, V., Szajnberg, N. M., Hyams, J. S., Treem, W. R., & Davis, P. M. (1995) · Perceptual and Motor Skills · doi:10.2466/pms.1995.80.3c.1341 · Cited by 6
von Wietersheim, J. (1994) · PubMed · Cited by 1
Flagged first, then by citations
1 of the 42 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Thomsen, 2002, Am J Gastroenterol, 97, 649, 10.1111/j.1572-0241.2002.05544.x · DOI
- Martin, 1995, Ital J Gastroenterol, 27, 450
- Porcelli, 1994, Ital J Gastroenterol, 26, 111
- von Wietersheim, 1994, Z Psychosom Med Psychoanal, 40, 68
- Alonso, 1995, Med Clin (Barc), 104, 771
Cited by
Sorted by citations
SF-36 total score as a single measure of health-related quality of life: Scoping review
Lins-Kusterer, L., & Carvalho, F. M. (2016) · SAGE Open Medicine · doi:10.1177/2050312116671725 · Cited by 1,182
Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management
Graff, L. A., Walker, J. R., & Bernstein, C. N. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20873 · Cited by 586
Mikocka-Walus, A., Knowles, S. R., Keefer, L., & Graff, L. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000620 · Cited by 567
ACG clinical guideline: Preventive care in inflammatory bowel disease
Farraye, F. A., Melmed, G. Y., Lichtenstein, G. R., & Kane, S. V. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.537 · Cited by 473
Risk factors of anxiety and depression in inflammatory bowel disease
Nahon, S., Lahmek, P., Durance, C., Olympie, A., Lesgourgues, B., Colombel, J., & Gendre, J. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22888 · Cited by 201
Abautret-Daly, Á., Dempsey, E., Parra‐Blanco, A., Medina, C., & Harkin, A. (2017) · Acta Neuropsychiatrica · doi:10.1017/neu.2017.3 · Cited by 186
Panara, A. J., Yarur, A. J., Rieders, B., Proksell, S., Deshpande, A. R., Abreu, M. T., & Sussman, D. A. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12669 · Cited by 168
Stress Coping, Distress, and Health Perceptions in Inflammatory Bowel Disease and Community Controls
Graff, L. A., Walker, J. R., Clara, I. P., Lix, L. M., Miller, N., Rogala, L., Rawsthorne, P. E., & Bernstein, C. N. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.529 · Cited by 126
The Influence of Depression on Quality of Life in Patients with Inflammatory Bowel Disease
Zhang, H., Hewett, J., Hemming, J., Grant, T., Zhao, H., Abraham, C., Oikonomou, I. K., Kanakia, M., Cho, J. H., & Proctor, D. D. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f395 · Cited by 117
Calvet, X., Panés, J., Alfaro, N., Hinojosa, J., Sicilia, B., Gallego, M., Pérez, I., Mercado, P. L. Y. D., & Gomollón, F. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.10.010 · Cited by 107
Self-citationImpact of Drug Therapy and Surgery on Quality of Life in Crohnʼs Disease
Wright, E. K., & Kamm, M. A. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000271 · Cited by 83
IsHak, W. W., Pan, D., Steiner, A. J., Feldman, E. J., Mann, A., Mirocha, J., Danovitch, I., & Melmed, G. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001060 · Cited by 83
Zhang, M., Hong, L., Zhang, T., Lin, Y., Zheng, S., Zhou, X., Fan, R., Wang, Z., Zhang, C.-L., & Zhong, J. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s118413 · Cited by 76
Horst, S., Chao, A., Rosen, M., Nohl, A., Duley, C., Wagnon, J. H., Beaulieu, D. B., Taylor, W., Gaines, L., & Schwartz, D. A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3375-0 · Cited by 75
Dempsey, E., Abautret-Daly, Á., Docherty, N. G., Medina, C., & Harkin, A. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.05.007 · Cited by 67
Use of thiopurines in inflammatory bowel disease: Safety issues
Konidari, A., & El‐Matary, W. (2014) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v5.i2.63 · Cited by 53
Role of Quality of Life as Endpoint for Inflammatory Bowel Disease Treatment
Calviño-Suárez, C., Ferreiro‐Iglesias, R., Bastón‐Rey, I., & Acosta, M. B. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18137159 · Cited by 49
ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease
Farraye, F. A., Melmed, G., Lichtenstein, G. R., Barnes, E. L., Limketkai, B. N., Caldera, F., & Kane, S. V. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003541 · Cited by 44
Casellas, F., Rodrigo, L., Niño, P., Pantiga, C., Riestra, S., & Malagelada, J. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20205 · Cited by 43
Self-citationEffect of Intestinal Resection on Quality of Life in Crohn's Disease
Wright, E. K., Kamm, M. A., Cruz, P. P. D., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Gorelik, A., Liew, D., Prideaux, L., Lawrance, I. C., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv058 · Cited by 35
Abautret-Daly, Á., Dempsey, E., Riestra, S., de Francisco-García, R., Parra‐Blanco, A., Rodrigo, L., Medina, C., Connor, T. J., & Harkin, A. (2017) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2017.1306081 · Cited by 36
Health related quality of life in patients with Cohn's disease in remission
Iglesias, M., Vázquez, I., Acosta, M. B., Figueiras, A., Nieto, L., Piñeiro‐Lamas, M., Gómez, R., LORENZO, A. D., & Domínguez‐Muñoz, J. E. (2010) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082010001100002 · Cited by 27
Calloway, A. P., Dalal, R. L., Beaulieu, D. B., Duley, C., Annis, K. A., Gaines, L. S., Slaughter, C., Schwartz, D. A., & Horst, S. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4800-y · Cited by 28
Vergara, M., Montserrat, A., Casellas, F., Maudsley, M., Gallardo, O., Ricart, E., & Calvet, X. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32830f4c9e · Cited by 24
Self-citationBastida, G., Nos, P., Aguas, M., Beltrán, B., Iborra, M., Ortiz, V., Garrigues, V., Estevan, R., & Ponce, J. D. C. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-26 · Cited by 25
Health Maintenance in Inflammatory Bowel Disease
Mir, F., & Kane, S. V. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0621-1 · Cited by 19
Evaluation of Brain Activity Using Near-infrared Spectroscopy in Inflammatory Bowel Disease Patients
Fujiwara, T., Kono, S., Katakura, K., Abe, K., Takahashi, A., Gunji, N., Yokokawa, A., Kawashima, K., Suzuki, R., Wada, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18897-4 · Cited by 17
(2009) · PubMed · Cited by 14
Zhao, E., Yu, Q., Abdoulaye, I. A., Mu, Y., Shi, Y., & Zhu, L. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.06.002 · Cited by 13
Zhang, M., Zhang, T., Hong, L., Zhang, C., Zhou, J., Fan, R., Wang, L., Wang, Z., Xu, B., & Zhong, J. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s156883 · Cited by 11
Impact of surgery on quality of life in Crohn’s disease: short- and mid-term follow-up
D’Ugo, S., Romano, F., Sibio, S., Bagaglini, G., Sensi, B., Biancone, L., Monteleone, G., & Sica, G. S. (2020) · Updates in Surgery · doi:10.1007/s13304-020-00738-1 · Cited by 11
Barnes, A., Bryant, R. V., Mukherjee, S., Spizzo, P., & Mountifield, R. E. (2024) · JGH Open · doi:10.1002/jgh3.70021 · Cited by 6
Parra, M. L., Dosal, A., Villòria, A., Moreno, L., & Calvet, X. (2015) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000103 · Cited by 5
Self-citationCrohn's disease, feeling well or healthy?
Casellas, F. (2010) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082010001100001 · Cited by 5
Self-citationAnalysis quality of life of Crohn’s disease patients based on the sf-36 questionnaire
Хавкин, А. И., Новикова, В. П., Nalyotov, A. V., Iotova, Y. T., Богданова, Е. А., Yablokova, E. A., & Ильинична, Е. М. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-221-1-92-98 · Cited by 4
Hmar, E. B. L., Paul, S., Boruah, N., Sarkar, P., Borah, S., & Sharma, H. K. (2021) · Current Pathobiology Reports · doi:10.1007/s40139-020-00218-6 · Cited by 4
Taxonera, C., López–Sanromán, A., Vera‐Mendoza, I., Domènech, E., Ruiz, V. V., Marín‐Jiménez, I., Guardiola, J., de Castro, L., Esteve, M., Iglesias, E. L., et al. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.01.002 · Cited by 3
Self-citationХавкин, А. И., Михайлович, Н. К., Nikolaeva, V. D., Veremenko, A. S., Дмитриевна, Л. И., Platonova, P. Y., Novikova, M. F., Tumas, A. S., Евгеньевна, В. Е., Shrayner, E. V., et al. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-228-8-258-272 · Cited by 3
The Role of Self-Compassion for Adjustment to Inflammatory Bowel Disease
Yeates, R., & Rowse, G. (2025) · Springer eBooks · doi:10.1007/978-3-031-89095-6_21 · Cited by 1
Quality of Life in Crohn’s Disease
Wexner, S. D., & Frattini, J. C. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_127 · Cited by 1
Casellas, F., de Guise, C. H., Robles, V., Torrejón, A., Navarro, E., & Borruel, N. (2015) · Enfermedad Inflamatoria Intestinal al Día · doi:10.1016/j.eii.2014.12.001 · Cited by 1
Self-citationQuality of life in patients with Crohn's disease
Gabalec, L. (2007) · Cited by 1
Sintomas depressivos em pacientes com doença de Crohn e sua relação com o fenótipo da doença
Facanali, C. B. G. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2022.tde-19122022-190513
Insomnia is associated with reduced quality of life in inflammatory bowel diseasePreprint
Barnes, A., Bryant, R. V., Mukherjee, S., Spizzo, P., & Mountifield, R. E. (2024) · Research Square · doi:10.21203/rs.3.rs-3810361/v1
Metadata
- Authors
- Calvet, X., Gallardo, O., Coronas, R., Casellas, F., Montserrat, A., Torrejón, A., Vergara, M., Campo, R., & Brullet, E.
- Affiliations
- Universitat Autònoma de Barcelona (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-08
- Volume
- 12
- Issue
- 8
- Pages
- 692-696
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W2008566769
- Cited by
- 45
- References
- 42
- Citations by year
- 2025: 3 · 2024: 3 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 3 · 2015: 3 · 2014: 4 · 2013: 2 · 2012: 1
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Inflammatory Bowel Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Instituto de Salud Carlos III (C03/02)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- Crohn's disease
- MeSH terms
- Adult, Anxiety, Crohn Disease, Depression, Female, Humans, Immunosuppressive Agents, Male, Quality of Life, Remission Induction, Mercaptopurine, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
